期刊文献+

脑静脉窦血栓形成致肌张力障碍康复1例报道

Rehabilitation for Dystonia post Cerebral Venous Sinus Thrombosis: A Case Report
下载PDF
导出
摘要 目的探讨脑静脉窦血栓形成所致肌张力障碍的临床特点及康复方法。方法报道1例脑静脉窦血栓形成患者,并结合文献分析。结果和结论经过抗凝治疗,神经功能缺损症状主要表现为左侧肢体活动不灵伴变形性肌张力障碍,经过康复训练、背肌局部治疗肉毒素后运动功能改善。 Objective To explore the features and rehabilitation of dystonia after cerebral venous sinus thrombosis. Methods A case was reviewed combined with literatures. Results and Conclusion The patient presented deformation dystonia after thrombolysis, and the func-tion improved after botulinum toxin injection and rehablitation.
出处 《中国康复理论与实践》 CSCD 北大核心 2014年第1期82-84,共3页 Chinese Journal of Rehabilitation Theory and Practice
关键词 脑静脉窦血栓 变形性肌张力障碍 肉毒毒素 康复 cerebral venous sinus thrombosis deformation dystonia botulinum toxin rehabilitation
  • 相关文献

参考文献8

  • 1展淑琴,吴海琴.颅内静脉窦血栓形成研究进展[J].中风与神经疾病杂志,2004,21(6):568-570. 被引量:33
  • 2李存江,王桂红,王拥军,宿英英.脑静脉窦血栓形成的早期诊断与治疗[J].中华神经科杂志,2002,35(2):65-67. 被引量:143
  • 3Fahn S. Concept and classification of dystonia[J].{H}ADVANCES IN NEUROLOGY,1988.1-8.
  • 4肌张力障碍诊断与治疗指南[J].中华神经科杂志,2008,41(8):570-573. 被引量:70
  • 5Vidailhet M. Treatment of movement disorders in dystonia-cho-reoathtosis cerebral palsy[J].Handb Clin Neurol,2013.197-202.
  • 6Nijmeijer SW,Koelman JH,Standaar TS. Cervical dysto-nia:improved treatment response to botulinum toxin after refer-ral to a tertiary centre and the use of polymyography[J].Par-kinsonism Relat Disord,2013,(05):533-538.
  • 7Batla A,Stamelou M,Bhatia KP. Treatment of focal dysto-nia[J].{H}Current Treatment Options in Neurology,2012,(03):213-229.
  • 8Zoons E,Dijkgraaf MG,Dijk JM. Botulinum toxin as treatment for focal dystonia:a systematic review of the pharma-co-therapeutic and pharmaco-economic value[J].{H}Journal of Neurology,2012,(12):2519-2526.

二级参考文献29

  • 1Albanese A, Barnes MP, Bhatia KP, et al. A systematic review on the diagnosis and treatment of primary ( idiopathic ) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force. EurJ Neurol, 2006,13: 433-444.
  • 2Klein C, Friedman J, Bressman S, et al. Genetic testing for earlyonset torsion dystonia ( DYT1 ) : introduction of a simple screening method, experiences from testing of a large patient cohort, and ethical aspects. Genet Test, 1999, 3:323-328 .
  • 3Bressman SB, Sabatti C, Raymond D, et al. The DYT1 phenotype and guidelines for diagnostic testing. Neurology, 2000, 54: 1746- 1752.
  • 4Robinson R, McCarthy GT, Bandmann O, et al. GTP cyclohydrolase deficiency; intrafamilial variation in clinical phenotype, including levodopa responsiveness. J Neurol Neurosurg Psychiatry, 1999, 66 : 86-89.
  • 5Valente EM, Edwards MJ, Mir P, et al. The epsilon-sarcoglycan gene in myoclonic syndromes. Neurology, 2005, 64: 737-739.
  • 6Meunier S, Lehericy S, Gamero L, et al. Dystonia: lessons from brain mapping . Neuroscientist, 2003, 9: 76-81.
  • 7Jankovic J. Treatment of dystonia. Lancet Neurol, 2006, 5 : 864- 872.
  • 8Berardelli A, Abbruzzese G, Bertolasi L, et al. Guidelines for the therapeutic use of botulinum toxin in movement disorders. Italian Study Group for Movement Disorders, Italian Society of Neurology. Ital J Neurol Sci, 1997, 18: 261-269.
  • 9Tarsy D, Simon DK. Dystonia. N Engl J Med, 2006,355:818- 829.
  • 10Geyer H, Bressman SB. The diagnosis of dystonia. Lancet Neurol, 2006, 5: 780-790.

共引文献239

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部